Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer
Thu, 24 Mar 2022 11:33:46 -0400
Italiano
Thu, 24 Mar 2022 11:33:46 -0400
Thu, 24 Mar 2022 10:36:14 -0400
Thu, 24 Mar 2022 09:26:46 -0400
Thu, 24 Mar 2022 09:11:21 -0400
For the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal-growth factor receptor (EGFR) Exon 20 insertion mutations whose disease has progressed on, or after platinum-based chemotherapy.
Wed, 23 Mar 2022 10:18:05 -0400
): Certain Point of Care Celltrion USA’s DiaTrust COVID-19 Ag Rapid Tests are being recalled because they were labeled for Research Use Only but distributed to customers for non-research, unauthorized uses are being recalled.
Tue, 22 Mar 2022 14:18:09 -0400
For the treatment of human leukocyte antigen (HLA)-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Come spesso accade – anche se non sempre risulta apparente – un unico “filo rosso” lega in maniera indissolubile ricercatori, pediatri e bambini. Nel nostro caso, si tratta dei cosiddetti farmaci off-label che rappresentano circa il 50% delle potenziali prescrizioni in età pediatrica. Parliamo di un’ampia gamma di principi attivi per i quali non esiste ancora l’autorizzazione all’uso nei bambini e che, nonostante questo, vengono comunemente impiegati, in tutto il mondo, con indicazioni, dosaggi e formulazioni non specificamente approvati per l’età pediatrica (Tabella 1).1-4
Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots (listed below) of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer level.
Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes to the consumer level. The batches in the table below are being recalled due to the potential
80.211.154.110